Please assess the completion status of the following clinical trial:

Trial Title: Bolus of Saline in Stroke

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years~* Acute ischemic stroke in the territory of the anterior, middle, or posterior cerebral artery territory on either side of the brain~* Study intervention can be initiated within 96 hours of symptom onset~* Willingness and ability to sign informed consent by patient or legally acceptable surrogate decision-maker~Exclusion Criteria:~* Infarct limited to the brainstem and/or cerebellum with no involvement of the cerebral hemispheres~* Bi-hemispheric infarction or acute infarct in the contra-lateral hemisphere within the past 30 days~* Symptoms of active congestive heart failure (dyspnea, orthopnea, increased oxygen requirement)~* Exacerbation of congestive heart failure, requiring hospitalization, within the past 30 days or severe systolic dysfunction with a known ejection fraction \<20%~* End stage renal disease requiring hemodialysis or a creatinine clearance \<20 ml/min/1.73 m2~* Hemicraniectomy or other skull defect that would interfere with monitoring~* Pregnant women are excluded. Women of child-bearing age must have a negative pregnancy test prior to enrollment~* Participation in another clinical trial~* Any other illness or condition that the investigator feels would pose a hazard to the subject from participation in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 110 Years
- Healthy Volunteers: f

Study Arms:
- Normal Saline (Type: EXPERIMENTAL): intravenous administration of 500cc of 0.9% NaCl over 30 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).